EUVIMED · CrossrefZeitschrift
BMJ Oncology
ISSN 2752-7948 · BMJ
Neueste Artikel
Data supply chain for cancer control and healthcare: motivation and principles
Trustworthy cancer data: from principles to practice
Foundation models in computational pathology: methods, applications and clinical implications
Temporal trends in behavioural risk factors for cancers with rising incidence in younger adults: an analysis of population-based data in England
First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours
Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging
Circulating-tumour DNA (ctDNA) in NSCLC: mechanisms, evidence and the future of MRD detection
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials
Treatment of oligometastatic lung cancers: new data, new drivers, new approaches
When herds overgraze: the cost of conformity in oncology drug development
Efficacy of nivolumab plus relatlimab versus BRAF/MEK inhibitors for first-line treatment of BRAF -mutant advanced melanoma: A matching-adjusted indirect comparison
Digital twins in oncology: where we are and where we hope to go
KRAS-targeted therapies in cancer: novel approaches and overcoming resistance
Impact of loneliness on cancer mortality: a systematic review and meta-analysis
Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancers
Clinical prediction models using machine learning in oncology: challenges and recommendations
Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma
Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM)
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data
Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical care
Large language models in oncology: a review
Disease-free survival as a surrogate for overall survival in early-stage pancreatic cancer trials: a correlation meta-analysis
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression
Im proving pa tient unde r standing of GEP te st r esults (I MPARTER4 ): an RCT
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
Bedside implications of the use of surrogate endpoints in solid and haematological cancers: implications for our reliance on PFS, DFS, ORR, MRD and more
Associations between socioeconomic factors and PSA testing in a population-based organised testing programme and routine healthcare: a register-based study of 50-year-old men
Circulating tumour cell clusters: isolation, biological significance and therapeutic implications
Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitors
EUVIMED